Entry Point Capital, LLC Lantheus Holdings, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
Shares
1 transactions
Others Institutions Holding LNTH
# of Institutions
529Shares Held
67.2MCall Options Held
1.19MPut Options Held
837K-
Black Rock Inc. New York, NY8.6MShares$732 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.42MShares$632 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.33MShares$284 Million0.15% of portfolio
-
State Street Corp Boston, MA2.49MShares$212 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.28MShares$194 Million0.89% of portfolio
About Lantheus Holdings, Inc.
- Ticker LNTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 68,741,904
- Market Cap $5.85B
- Description
- Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...